膀胱影像报告与数据系统:克服全球实施的障碍——AJR专家小组叙述性综述
本AJR专家小组叙述性综述指出,VI-RADS自2018年推出以来已成为膀胱癌多参数MRI评估的标准化且可重复的框架,在区分肌层浸润性疾病与非肌层浸润性疾病方面具有经证实的诊断准确性,但实际临床采用仍有限。文章探讨了实施障碍并提出战略建议,包括标准化膀胱MRI质量、结构化教育、完善治疗后VI-RADS方案和促进多学科协作。
要点
- VI-RADS是膀胱癌多参数MRI的标准化框架,可重复性好,诊断准确性经证实。
- VI-RADS在真实世界中的临床采用仍然有限,存在多方面实施障碍。
- 障碍包括转诊临床医生的怀疑、无法同时进行肿瘤切除、治疗后性能欠佳、图像质量和阅片者经验差异。
核心结论
- VI-RADS有潜力成为膀胱癌管理的基石,但膀胱MRI路径的验证和实施将取决于临床、技术和指南领域的持续完善、接受和协调一致。
研究设计与样本
- AJR专家小组叙述性综述,探讨VI-RADS全球实施障碍并提出战略建议。
诊断标准与关键数值
- VI-RADS用于多参数MRI评估膀胱癌,区分肌层浸润性疾病与非肌层浸润性疾病的诊断准确性已经验证。
临床应用与阅片要点
- 文章提出战略建议以应对实施挑战,包括标准化膀胱MRI质量、纳入结构化教育举措、完善治疗后环境下的VI-RADS方案以及促进多学科协作。
局限性
- 转诊临床医生存在怀疑。
- 与基于膀胱镜的分期不同,无法同时进行肿瘤切除。
- 治疗后性能欠佳。
- 图像质量和阅片者经验存在变异性。
- 在专科中心之外的可及性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Since its introduction in 2018, VI-RADS has emerged as a standardized and reproducible framework for multiparametric MRI assessment of bladder cancer, with validated diagnostic accuracy in distinguishing muscle-invasive disease from non-muscle-invasive disease. Despite growing international interest, expert consensus, and the system's inclusion in most major guidelines, real-world clinical adoption of VI-RADS remains limited. This AJR Expert Panel Narrative Review explores the key barriers that hinder implementation of VI-RADS into everyday workflows across diverse health care settings, including skepticism among referring clinicians, an inability (unlike with cystoscopy-based staging) to perform simultaneous tumor resection, suboptimal posttreatment performance, and variability in image quality and reader experience. Additional logistic and economic factors, including restricted access outside of specialized centers and limited cost-effectiveness data, further impair widespread uptake. This article outlines strategic recommendations to address these challenges, including standardizing bladder MRI quality, incorporating structured educational initiatives, refining VI-RADS protocols for posttreatment settings, and fostering multidisciplinary collaboration. VI-RADS has the potential to become a cornerstone of bladder cancer management, but the validation and implementation of a bladder-MRI pathway will depend on continued refinement, acceptance, and alignment across clinical, technical, and guideline domains.
引用
- Dehghanpour A, Davenport MS, Muglia VF, et al. Vesical Imaging Reporting and Data System: Overcoming Barriers to Global Implementation-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2025. PMID: 40899674. doi:10.2214/AJR.25.33634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。